These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25797899)

  • 1. Polymer-immobilized ready-to-use recombinant yeast assays for the detection of endocrine disruptive compounds.
    Bittner M; Jarque S; Hilscherová K
    Chemosphere; 2015 Aug; 132():56-62. PubMed ID: 25797899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freeze-drying as suitable method to achieve ready-to-use yeast biosensors for androgenic and estrogenic compounds.
    Jarque S; Bittner M; Hilscherová K
    Chemosphere; 2016 Apr; 148():204-10. PubMed ID: 26807940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of methods of detection of water estrogenicity for their use as monitoring tools in a process of estrogenicity removal.
    Blavier J; Songulashvili G; Simon C; Penninckx M; Flahaut S; Scippo ML; Debaste F
    Environ Technol; 2016 Dec; 37(24):3104-19. PubMed ID: 27144327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring potential contributors to endocrine disrupting activities in Taiwan's surface waters using yeast assays and chemical analysis.
    Chou PH; Lin YL; Liu TC; Chen KY
    Chemosphere; 2015 Nov; 138():814-20. PubMed ID: 26295540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of recombinant Lac Z reporter gene-transformed yeast cells for bioassay of androgen-like compounds in environment].
    Dai W; Yang C; Luo F; Li S; Huang R; Xie Y; Xue F; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):303-9. PubMed ID: 23643090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors.
    Ezechiáš M; Janochová J; Filipová A; Křesinová Z; Cajthaml T
    Chemosphere; 2016 Jun; 152():284-91. PubMed ID: 26978704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioluminescent yeast estrogen assay (BLYES) as a sensitive tool to monitor surface and drinking water for estrogenicity.
    Bergamasco AM; Eldridge M; Sanseverino J; Sodré FF; Montagner CC; Pescara IC; Jardim WF; Umbuzeiro Gde A
    J Environ Monit; 2011 Nov; 13(11):3288-93. PubMed ID: 22041933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical approach for monitoring endocrine-disrupting compounds in urban waste water treatment plants.
    Roda A; Mirasoli M; Michelini E; Magliulo M; Simoni P; Guardigli M; Curini R; Sergi M; Marino A
    Anal Bioanal Chem; 2006 Jun; 385(4):742-52. PubMed ID: 16741774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of endocrine disruptors in surface waters by the yeast recombinant assay.
    García-Reyero N; Grau E; Castillo M; López de Alda MJ; Barceló D; Piña B
    Environ Toxicol Chem; 2001 Jun; 20(6):1152-8. PubMed ID: 11392124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of environmental endocrine disrupting activities using recombinant yeast assay in wastewater treatment plant effluents.
    Li J; Wang Z; Ma M; Peng X
    Bull Environ Contam Toxicol; 2010 May; 84(5):529-35. PubMed ID: 20407748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized yeast-based in vitro bioassay for determination of estrogenic and androgenic activity of hydroxylated / methoxylated metabolites of BDEs / CBs and related lipophilic organic pollutants.
    Roszko M; Kamińska M; Szymczyk K; Piasecka-Jóźwiak K; Chabłowska B
    J Environ Sci Health B; 2018; 53(10):692-706. PubMed ID: 29775424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of environmental endocrine disrupting activities in wastewater treatment plant effluents using recombinant yeast assays incorporated with exogenous metabolic activation system.
    Li J; Chen M; Wang Z; Ma M; Peng X
    Biomed Environ Sci; 2011 Apr; 24(2):132-9. PubMed ID: 21565684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bioluminescent NanoLuc yeast-estrogen screen biosensor (nanoYES) with a compact wireless camera for effect-based detection of endocrine-disrupting chemicals.
    Cevenini L; Lopreside A; Calabretta MM; D'Elia M; Simoni P; Michelini E; Roda A
    Anal Bioanal Chem; 2018 Feb; 410(4):1237-1246. PubMed ID: 28965124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific in vitro toxicity of crude and refined petroleum products: II. Estrogen (alpha and beta) and androgen receptor-mediated responses in yeast assays.
    Vrabie CM; Candido A; van Duursen MB; Jonker MT
    Environ Toxicol Chem; 2010 Jul; 29(7):1529-36. PubMed ID: 20821602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish-based reporter gene assays reveal different estrogenic activities in river waters compared to a conventional human-derived assay.
    Sonavane M; Creusot N; Maillot-Maréchal E; Péry A; Brion F; Aїt-Aïssa S
    Sci Total Environ; 2016 Apr; 550():934-939. PubMed ID: 26851879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection.
    Michelini E; Leskinen P; Virta M; Karp M; Roda A
    Biosens Bioelectron; 2005 May; 20(11):2261-7. PubMed ID: 15797324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of endocrine active substances in the aquatic environment in southern Taiwan using bioassays and LC-MS/MS.
    Chen KY; Chou PH
    Chemosphere; 2016 Jun; 152():214-20. PubMed ID: 26971174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Arxula Yeast Estrogen Screen assay for detection of estrogenic activity in water samples: Results of an international interlaboratory study.
    Hettwer K; Jähne M; Frost K; Giersberg M; Kunze G; Trimborn M; Reif M; Türk J; Gehrmann L; Dardenne F; De Croock F; Abraham M; Schoop A; Waniek JJ; Bucher T; Simon E; Vermeirssen E; Werner A; Hellauer K; Wallentits U; Drewes JE; Dietzmann D; Routledge E; Beresford N; Zietek T; Siebler M; Simon A; Bielak H; Hollert H; Müller Y; Harff M; Schiwy S; Simon K; Uhlig S
    Sci Total Environ; 2018 Apr; 621():612-625. PubMed ID: 29195208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular recognition of endocrine disruptors by synthetic and natural 17beta-estradiol receptors: a comparative study.
    Tse Sum Bui B; Belmont AS; Witters H; Haupt K
    Anal Bioanal Chem; 2008 Apr; 390(8):2081-8. PubMed ID: 18368394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.